Study Stopped
No funds are available to support implementation of this project.
Cerebral pAlsy Motor Promotion With Transcranial Direct Current Stimulation (CAMP-tDCS)
Concurrent Transcranial Direct Current Stimulation and Constraint-induced Movement Therapy in Children With Hemiplegic Cerebral Palsy: A Randomized Controlled Study on Efficacy and Brain Mechanisms
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This study aims to test if transcranial direct current stimulation (tDCS) can be applied to boost the efficacy of constraint-induced movement therapy (CIMT) in children with HCP and examine brain mechanisms related to individual outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2024
CompletedFirst Posted
Study publicly available on registry
February 2, 2024
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
July 10, 2025
July 1, 2025
2 years
January 17, 2024
July 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
gross manual dexterity
It will be measured by the box and block test to assess how many blocks one can move from one box to another in one minute.
With the first day of the intervention defined as day 1, this measure will be assessed in one of the three days before day 1, on day 15 or day 16 or day 17, and on day 181 or day 182 or day 183.
fine manual dexterity
It will be measured by the nine-hole peg test to assess the time one needs to place nine pins into a reservior.
With the first day of the intervention defined as day 1, this measure will be assessed in one of the three days before day 1, on day 15 or day 16 or day 17, and on day 181 or day 182 or day 183.
Secondary Outcomes (2)
quality of upper extremity skill
With the first day of the intervention defined as day 1, this measure will be assessed in one of the three days before day 1, on day 15 or day 16 or day 17, and on day 181 or day 182 or day 183.
finger touch sensitivity
With the first day of the intervention defined as day 1, this measure will be assessed in one of the three days before day 1, on day 15 or day 16 or day 17, and on day 181 or day 182 or day 183.
Study Arms (2)
tDCS+CIMT
EXPERIMENTALParticipants will receive concurrent anodal tDCS (20 minutes, 1mA\~2mA) and CIMT (2 hours) five days a week for three weeks in a row.
sham+CIMT
SHAM COMPARATORParticipants will receive concurrent sham tDCS and CIMT (2 hours) five days a week for three weeks in a row.
Interventions
tDCS will be delivered anodal for 20 minutes at an intensity between 1mA and 2mA for 15 sessions.
CIMT will be administered for two hours a day, five days a week, and three weeks in a row.
Eligibility Criteria
You may qualify if:
- formal diagnosis of hemiplegic cerebral palsy
- unilateral upper limb (arm and hand) motor and sensory impairments
- capable of understanding and following experimental instructions and procedures
- capable of performing study procedures without assistance
- years of age, including 5-year-old and 17-year-old
You may not qualify if:
- brain surgery, peripheral nerve surgery, genetic disorders, other neurological disorders or injuries
- muscle toxin injection within six months before recruitment
- received constraint-induced movement therapy (CIMT) within one year before recruitment
- uncontrolled seizures within one year before recruitment
- orthopedic surgery in upper limb within one year before recruitment
- incapable of understanding and following experimental instructions and procedures
- non-removable metallic objects or infusion pumps in the body
- psychoactive or myorelaxant medication during study procedures
- less than five years of age and older than 17 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Texas Southwestern Medical Centerlead
- Children's Healthcollaborator
Study Sites (1)
Children's Health Medical Center Dallas
Dallas, Texas, 75235, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yanlong Song, PhD
University of Texas Southwestern Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 17, 2024
First Posted
February 2, 2024
Study Start
January 1, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
July 10, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- IPD and supporting information will be shared at the end of the study.
- Access Criteria
- Access to the shared IPD and supporting information will not be controlled.
Participants' identifiers and linkages between study IDs and participants' identifiers will not be shared to protect participants' privacy, rights, and confidentiality. All other individual participant data will be preserved and shared. All data to be shared will be de-identified prior to receipt by any data repository. The information needed to generate a global unique identifier for a repository will be kept for each participant.